Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
93,855,130
-
Share change
-
+635,512
-
Total reported value
-
$579,165,785
-
Put/Call ratio
-
84%
-
Price per share
-
$6.18
-
Number of holders
-
128
-
Value change
-
+$2,213,720
-
Number of buys
-
64
-
Number of sells
-
59
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q2 2014
As of 30 Jun 2014,
OREXIGEN THERAPEUTICS INC - COM (OREX) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,855,130 shares.
The largest 10 holders included
FMR LLC, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, Partner Fund Management, L.P., BlackRock Fund Advisors, State Street Corp, FRANKLIN RESOURCES INC, BANK OF AMERICA CORP /DE/, BlackRock Institutional Trust Company, N.A., and VANGUARD GROUP INC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.